Back
Cara Therapeutics Stock Price Chart
Sponsored
CARA
Sponsored
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Buy
51
CARA
Cara Therapeutics
Last Price:
0.35
Seasonality Move:
3.84%
7 Day Trial
ALL ACCESS PASS
$
7
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CARA is experiencing slight buying pressure.
Cara Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.32 | Buy |
20-day SMA: | 0.29 | Buy |
50-day SMA: | 0.29 | Buy |
200-day SMA: | 0.52 | Sell |
8-day EMA: | 0.32 | Buy |
20-day EMA: | 0.3 | Buy |
50-day EMA: | 0.3 | Buy |
200-day EMA: | 0.73 | Sell |
Cara Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 68.3 | Buy |
Chaikin Money Flow: | 473415 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.25 - 0.31) | Buy |
Bollinger Bands (100): | (0.27 - 0.35) | Buy |
Cara Therapeutics Technical Analysis
Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Cara Therapeutics Stock
Is Cara Therapeutics Stock a Buy?
- Cara Therapeutics share price is 0.34 while CARA 8-day simple moving average is 0.32, which is a Buy signal.
- The stock price of CARA is 0.34 while Cara Therapeutics 20-day SMA is 0.29, which makes it a Buy.
- Cara Therapeutics 50-day simple moving average is 0.29 while CARA share price is 0.34, making it a Buy technically.
- CARA stock price is 0.34 and Cara Therapeutics 200-day simple moving average is 0.52, creating a Sell signal.
CARA Technical Analysis vs Fundamental Analysis
Buy
51
Cara Therapeutics (CARA)
is a Buy
Is Cara Therapeutics a Buy or a Sell?
-
Cara Therapeutics stock is rated a Buy
The current Cara Therapeutics [CARA] share price is $0.34. The Score for CARA is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
Cara Therapeutics Stock Info
Market Cap:
18.7M
Price in USD:
0.34
Share Volume:
1.11M
Cara Therapeutics 52-Week Range
52-Week High:
1.31
52-Week Low:
0.24
Buy
51
Cara Therapeutics (CARA)
is a Buy
Cara Therapeutics Share Price Forecast
-
What is the Cara Therapeutics stock price today?
The Cara Therapeutics stock price is 0.34 USD today. -
Will CARA stock go up or go down?
Cara Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Cara Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cara Therapeutics is not overvalued.
Is Cara Therapeutics Stock a Buy?
- Cara Therapeutics share price is 0.34 while CARA 8-day exponential moving average is 0.32, which is a Buy signal.
- The stock price of CARA is 0.34 while Cara Therapeutics 20-day EMA is 0.30, which makes it a Buy.
- Cara Therapeutics 50-day exponential moving average is 0.30 while CARA share price is 0.34, making it a Buy technically.
- CARA stock price is 0.34 and Cara Therapeutics 200-day simple moving average is 0.73, creating a Sell signal.
Fundamental Analysis of Cara Therapeutics
Is Cara Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and an increase next year of $0.50 per share.
Technical Analysis of Cara Therapeutics
Should I short Cara Therapeutics stock?
- CARA Moving Average Covergence Divergence (MACD) indicator is 0.01, suggesting Cara Therapeutics is a Buy
- Cara Therapeutics Relative Strength Index (RSI) is 68.3, which suggest Cara Therapeutics is overbought
- The Bollinger Bands (25) for Cara Therapeutics is (0.25 - 0.31), which suggest Cara Therapeutics is a Buy
- The Bollinger Bands (100) for Cara Therapeutics is (0.27 - 0.35), which suggest Cara Therapeutics is a Buy
* Cara Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.